Literature DB >> 19749004

Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

Seok-Yong Eum1, Ji-Hye Kong, Min-Sun Hong, Ye-Jin Lee, Jin-Hee Kim, Soo-Hee Hwang, Sang-Nae Cho, Laura E Via, Clifton E Barry.   

Abstract

BACKGROUND: The exact role of neutrophils in the pathogenesis of TB is poorly understood. Recent evidence suggests that neutrophils are not simply scavenging phagocytes in Mycobacterium tuberculosis (Mtb) infection.
METHODS: Three different types of clinical specimens from patients with active pulmonary TB who underwent lung surgery were examined: sputum, BAL fluid, and cavity contents. Differential cell separation and quantification were performed for intracellular and extracellular bacteria, and bacterial length was measured using microscopy.
RESULTS: Neutrophils were more abundant than macrophages in sputum (86.6% +/- 2.2% vs 8.4% +/- 1.3%) and in BAL fluid (78.8% +/- 5.8% vs 11.8% +/- 4.1%). Inside the cavity, lymphocytes (41.3% +/- 11.2%) were the most abundant cell type, followed by neutrophils (38.8% +/- 9.4%) and macrophages (19.5% +/- 7.5%). More intracellular bacilli were found in neutrophils than macrophages in sputum (67.6% +/- 5.6% vs 25.2% +/- 6.5%), in BAL fluid (65.1% +/- 14.4% vs 28.3% +/- 11.6%), and in cavities (61.8% +/- 13.3% vs 23.9% +/- 9.3%). The lengths of Mtb were shortest in cavities (1.9+/- 0.1 microm), followed by in sputum (2.9 +/- 0.1 microm) and in BAL fluid (3.6 +/- 0.2 microm).
CONCLUSIONS: Our results show that neutrophils are the predominant cell types infected with Mtb in patients with TB and that these intracellular bacteria appear to replicate rapidly. These results are consistent with a role for neutrophils in providing a permissive site for a final burst of active replication of the bacilli prior to transmission.

Entities:  

Mesh:

Year:  2009        PMID: 19749004      PMCID: PMC2803122          DOI: 10.1378/chest.09-0903

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  44 in total

Review 1.  The host immune response to tuberculosis.

Authors:  N W Schluger; W N Rom
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

2.  Sputum induction for the diagnosis of tuberculosis.

Authors:  A M Shata; J B Coulter; C M Parry; G Ching'ani; R L Broadhead; C A Hart
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

3.  Quality evaluation of sputum specimens for mycobacterial culture.

Authors:  Y S McCarter; A Robinson
Journal:  Am J Clin Pathol       Date:  1996-06       Impact factor: 2.493

4.  The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculous infection and in vitro superoxide anion production.

Authors:  N Venkataprasad; P Ledger; J Ivanyi
Journal:  Int Arch Allergy Immunol       Date:  1997-09       Impact factor: 2.749

5.  Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules.

Authors:  V Witko-Sarsat; E M Cramer; C Hieblot; J Guichard; P Nusbaum; S Lopez; P Lesavre; L Halbwachs-Mecarelli
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

6.  Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043.

Authors:  K Fujie; Y Shinguh; N Inamura; R Yasumitsu; M Okamoto; M Okuhara
Journal:  Eur J Pharmacol       Date:  1999-06-11       Impact factor: 4.432

7.  Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.

Authors:  M Petrofsky; L E Bermudez
Journal:  Clin Immunol       Date:  1999-06       Impact factor: 3.969

8.  Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide.

Authors:  C Aston; W N Rom; A T Talbot; J Reibman
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

9.  Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis.

Authors:  K Kasahara; I Sato; K Ogura; H Takeuchi; K Kobayashi; M Adachi
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice.

Authors:  Evgenyi B Eruslanov; Irina V Lyadova; Tatiana K Kondratieva; Konstantin B Majorov; Ilya V Scheglov; Marianna O Orlova; Alexander S Apt
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

View more
  218 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.

Authors:  Prakash M Jeena; William R Bishai; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 4.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 5.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

6.  An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice.

Authors:  Vandana Kaul; Debapriya Bhattacharya; Yogesh Singh; Luc Van Kaer; Marc Peters-Golden; William R Bishai; Gobardhan Das
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

7.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.

Authors:  Radha Gopal; Leticia Monin; Diana Torres; Samantha Slight; Smriti Mehra; Kyle C McKenna; Beth A Fallert Junecko; Todd A Reinhart; Jay Kolls; Renata Báez-Saldaña; Alfredo Cruz-Lagunas; Tatiana S Rodríguez-Reyna; Nathella Pavan Kumar; Phillipe Tessier; Johannes Roth; Moisés Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Bridgette Cumming; Victoria O Kasprowicz; Adrie J C Steyn; Subash Babu; Deepak Kaushal; Joaquín Zúñiga; Thomas Vogl; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

9.  Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis.

Authors:  Smriti Mehra; Xavier Alvarez; Peter J Didier; Lara A Doyle; James L Blanchard; Andrew A Lackner; Deepak Kaushal
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

10.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.